Analysis of Factors Affecting Recurrence of Hepatocellular Carcinoma After Liver Transplantation With a Special Focus on Inflammation Markers
- 15 June 2011
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Transplantation
- Vol. 91 (11), 1279-1285
- https://doi.org/10.1097/tp.0b013e3182187cf0
Abstract
Background. Systemic inflammation markers, such as neutrophil-to-lymphocyte ratio (NLR), have recently emerged as the prognostic factors for recurrence of liver tumors. Methods. We assessed the ability of NLR and of other variables to predict the outcomes of orthotopic liver transplantation (OLT) for hepatocellular carcinoma (HCC). A retrospective analysis was performed in 219 patients with HCC who underwent OLT between 1997 and 2009, with a median follow-up of 40 months. Results. Overall 3- and 5-year patient survival rates were 76.6% and 70.7%, respectively. Overall 3- and 5-year recurrence-free survival (RFS) rates were 83.8% and 82.1%, respectively. On univariate analysis, the factors affecting overall survival were α-fetoprotein more than 30 ng/mL (P=0.006), NLR more than or equal to 5 (P<0.0001), hepatitis C infection (P=0.043), and presence of microvascular invasion (MVI; P=0.006). Preoperative treatments (P=0.006), α-fetoprotein more than 30 ng/mL (P=0.003), NLR more than or equal to 5 (P<0.0001), exceeding Milan criteria at final histology (P=0.001), poor tumor differentiation (P=0.02), and presence of MVI (P<0.0001) predicted a lower RFS. Cox's proportional hazard model showed that only increased NLR and presence of MVI independently predicted overall survival and RFS. Conclusions. NLR is an important predictor of outcome after OLT for HCC and should be used to identify OLT candidates at high risk of recurrence.This publication has 57 references indexed in Scilit:
- The evolution of liver transplantation for hepatocellular carcinoma (past, present, and future)The Esophagus, 2008
- Liver Transplantation for Hepatocellular CarcinomaGastroenterology, 2005
- Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance☆Gastroenterology, 2004
- Hepatocellular carcinomaThe Lancet, 2003
- Is liver transplantation superior to resection in early stage hepatocellular carcinoma?Transplantation Proceedings, 1999
- Liver Transplantation for the Treatment of Small Hepatocellular Carcinomas in Patients with CirrhosisThe New England Journal of Medicine, 1996
- Liver Resection Versus Transplantation for Hepatocellular Carcinoma in Cirrhotic PatientsAnnals of Surgery, 1993
- The 11 -year pittsburgh experience with liver transplantation for hepatocellular carcinoma: 1981-1991Journal of Surgical Oncology, 1993
- Hepatic Resection Versus Transplantation for Hepatocellular CarcinomaAnnals of Surgery, 1991
- Surgical treatment of hepatocellular carcinoma: Experience with liver resection and transplantation in 198 patientsWorld Journal of Surgery, 1991